Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial.

McMeekin, Nicola; Geue, Claudia; Briggs, Andrew; Rombach, Ines; Li, Ho Kwong; Bejon, Philip; McNally, Martin; Atkins, Bridget L; Ferguson, Jamie; Scarborough, Matthew; +1 more... OVIVA collaborators; (2019) Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial. Wellcome open research, 4. 108-. ISSN 2398-502X DOI: https://doi.org/10.12688/wellcomeopenres.15314.4

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.12688/wellcomeopenres.15314.4

Abstract

Share

Download

Filename: Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection evidence from a .pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar